Unraveling the role of heme in neurodegeneration

D Chiabrando, V Fiorito, S Petrillo… - Frontiers in …, 2018 - frontiersin.org
Heme (iron-protoporphyrin IX) is an essential co-factor involved in several biological
processes, including neuronal survival and differentiation. Nevertheless, an excess of free …

Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation

V Oliveri - European Journal of Medicinal Chemistry, 2019 - Elsevier
A host of human diseases, including Parkinson's disease and Dementia with Lewy bodies,
are suspected to be directly linked to protein aggregation. Amyloid protein aggregates and …

Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases

P Alam, SK Chaturvedi, MK Siddiqi, RK Rajpoot… - Scientific reports, 2016 - nature.com
Protein misfolding and aggregation have been associated with several human diseases
such as Alzheimer's, Parkinson's and familial amyloid polyneuropathy etc. In this study, anti …

Highly effective lead (II) removal by sustainable alkaline activated β-lactoglobulin nanofibrils from whey protein

Q Zhang, S Zhang, Z Zhao, M Liu, X Yin, Y Zhou… - Journal of Cleaner …, 2020 - Elsevier
In this work, we developed β-lactoglobulin nanofibrils by alkaline-thermal activation methods
for Pb removal. The protein fibrils exhibited effective adsorption and selectivity for lead (II) …

Iron chelation nanoparticles with delayed saturation as an effective therapy for Parkinson disease

N Wang, X Jin, D Guo, G Tong, X Zhu - Biomacromolecules, 2017 - ACS Publications
Iron accumulation in substantia nigra pars compacta (SNpc) has been proved to be a
prominent pathophysiological feature of Parkinson's diseases (PD), which can induce the …

Peroxynitrite scavenger FeTPPS binds with hCT to effectively inhibit its amyloid aggregation

B Xiao, J Xiao, S Liu, X Xiao, S Dai, Y Sui, J Wu… - Dalton …, 2024 - pubs.rsc.org
Human calcitonin (hCT) is an endogenous polypeptide commonly employed in treating
bone resorption-related illnesses, but its clinical application is limited due to its high …

Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation

F van Diggelen, D Hrle, M Apetri, G Christiansen… - PloS one, 2019 - journals.plos.org
Parkinson's Disease (PD) is a neurodegenerative disease for which there currently is no
cure. Aggregation of the pre-synaptic protein α-synuclein (aSN) into oligomers (αSOs) is …

Navigating α‐Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets

M Galkin, A Priss, Y Kyriukha… - The Chemical …, 2024 - Wiley Online Library
Parkinson's disease is a yet incurable, age‐related neurodegenerative disorder
characterized by the aggregation of small neuronal protein α‐synuclein into amyloid fibrils …

Mitochondrial targeting in neurodegeneration: a heme perspective

V Fiorito, D Chiabrando, E Tolosano - Pharmaceuticals, 2018 - mdpi.com
Mitochondrial dysfunction has achieved an increasing interest in the field of
neurodegeneration as a pathological hallmark for different disorders. The impact of …

Conformational distortion in a fibril-forming oligomer arrests alpha-Synuclein fibrillation and minimizes its toxic effects

R Chakraborty, S Dey, P Sil, SS Paul… - Communications …, 2021 - nature.com
The fibrillation pathway of alpha-Synuclein, the causative protein of Parkinson's disease,
encompasses transient, heterogeneous oligomeric forms whose structural understanding …